Welcome to our dedicated page for Acacia Resh SEC filings (Ticker: ACTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Acacia Research Corporation (Nasdaq: ACTG) SEC filings page on Stock Titan provides access to the companys regulatory disclosures, together with AI-generated summaries that help explain the content of each document. Acacia files periodic and current reports with the U.S. Securities and Exchange Commission as a Nasdaq-listed issuer.
Investors can review quarterly and annual reports, where Acacia presents consolidated financial statements and segment information for Energy Operations (Benchmark), Industrial Operations (Printronix), Manufacturing Operations (Deflecto) and Intellectual Property Operations (Acacia Research Group). These filings expand on topics highlighted in earnings releases, such as revenue composition, non-GAAP measures like Total Company Adjusted EBITDA and Operated Segment Adjusted EBITDA, and details of acquisitions and investments.
The filings page also includes Form 8-K current reports that Acacia uses to disclose material events. Recent examples referenced in the input include 8-Ks announcing quarterly financial results and the appointment of a Chief Financial Officer, along with a summary of the related employment agreement and indemnification arrangements. AI summaries on Stock Titan highlight the key items in each 8-K so readers can quickly understand what changed and why it matters.
Users interested in capital structure and investment activity can turn to Acacias SEC reports for information on cash, cash equivalents, equity securities, loans receivable and equity method investments, including its indirect stake in Viamet Pharmaceuticals, Inc. through MalinJ1. The filings also describe loans receivable that represent commercial loans collateralized by Bitcoin, connected to Acacias partnership with Unchained Capital.
Stock Titans interface surfaces these documents as they are posted to EDGAR and applies AI to summarize complex sections, helping readers navigate topics such as segment performance, non-GAAP reconciliations, executive arrangements and risk disclosures without having to parse every line of the underlying forms.
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Gavin Molinelli received a stock grant as compensation. On March 31, 2026, he was awarded 6,237 shares of common stock at $4.81 per share in lieu of cash for his Q1 2026 director fees. After this grant, he directly holds 174,476 shares of Acacia Research common stock. This is a compensatory share award, not an open-market purchase or sale.
ACACIA RESEARCH CORP director Ajay Sundar acquired 4,158 shares of Common Stock as compensation. The shares were granted on March 31, 2026 in lieu of cash for Q1 2026 director fees at a reference price of $4.81 per share, bringing his direct holdings to 103,430 shares.
Acacia Research Corp General Counsel Jason W. Soncini reported a tax-related share withholding, not an open-market sale. On the transaction date, 6,147 shares of ACTG common stock were withheld to cover tax obligations tied to the vesting of 15,252 restricted shares on March 21, 2026.
After this tax-withholding disposition, Soncini directly owns 191,551 shares of Acacia Research common stock. The event reflects routine equity compensation and associated tax treatment rather than discretionary buying or selling in the market.
Acacia Research Corp Chief Executive Officer Martin D. McNulty Jr. reported a tax-withholding disposition of 8,207 shares of ACTG Common Stock on March 10, 2026. These shares were withheld to satisfy tax obligations tied to the vesting of 20,000 restricted shares on the same date.
After this withholding, McNulty directly owned 166,403 shares of Acacia Research Corp common stock. This transaction reflects a compensation-related tax payment mechanism rather than an open-market purchase or sale.
Acacia Research Corporation files its Annual Report describing a diversified, acquisition-driven model spanning intellectual property, energy, industrial and manufacturing businesses. The company partners closely with controlling shareholder Starboard Value to source complex, often undervalued assets.
Acacia’s IP unit has executed over 1,600 license agreements and generated about $1.9 billion in gross licensing revenue since inception. The Energy Operations Business now owns roughly 73.5% of Benchmark Energy II, which acquired Anadarko Basin assets for $145 million and produced 2,081 Mboe in 2025.
Industrial and manufacturing operations include Printronix and Deflecto, the latter acquired for $103.7 million. Acacia has also largely monetized its Life Sciences Portfolio, receiving $564.1 million in proceeds through December 31, 2025. The filing highlights extensive risk factors around acquisition execution, integration, commodity exposure, regulation and dependence on key personnel and Starboard.
Acacia Research Corporation reported strong fourth quarter and full-year 2025 results, highlighted by record annual revenue of $285.2 million, up 133% from $122.3 million in 2024. Growth was driven by a full year of Manufacturing Operations and higher Energy and Intellectual Property revenue.
For Q4 2025, Acacia generated revenue of $50.1 million, GAAP net income of $3.4 million (diluted EPS of $0.04) and Adjusted Net Income of $3.1 million (Adjusted diluted EPS of $0.03). Total Company Adjusted EBITDA was $17.4 million, and Operated Segment Adjusted EBITDA was $22.4 million for the quarter.
For the full year 2025, GAAP net income reached $21.7 million (diluted EPS of $0.22), with Adjusted Net Income of $29.2 million (Adjusted diluted EPS of $0.30). Total Company Adjusted EBITDA rose to $77.9 million and Operated Segment Adjusted EBITDA to $96.4 million, both sharply higher than 2024. Year-end cash, cash equivalents, equity securities measured at fair value and loans receivable totaled $339.6 million, or $3.52 per share, supporting a book value per share of $6.05.
Acacia Research Corporation reported that board member Geoff Ribar has informed the company he will not stand for reelection at the 2026 Annual Meeting of Stockholders. He currently serves as chairman of the Board’s Nominating, Governance and Sustainability Committee and is a member of the Audit Committee.
The company states that Mr. Ribar’s decision, which he attributed to personal reasons including his time commitments to other boards, is not based on any disagreement with Acacia or its Board regarding operations, policies, or practices.
Acacia Research (ACTG) reported Q3 results showing higher revenue and narrower losses while integrating recent acquisitions across energy, industrial, and manufacturing operations.
Total revenue was $59.4 million, up from $23.3 million a year ago, led by manufacturing ($30.8 million) from the Deflecto business and stronger intellectual property licensing ($7.8 million, driven by paid-up licenses). Energy contributed $14.2 million and industrial $6.7 million. Operating loss improved to $6.4 million from $10.3 million, and net loss attributable to Acacia narrowed to $2.7 million, or $0.03 per share, from $14.0 million, or $0.14 per share.
For the nine months, revenue reached $235.1 million versus $73.5 million, with operating income of $19.5 million and net income of $18.3 million. Cash and cash equivalents were $301.8 million as of September 30, 2025. Benchmark’s revolving credit facility balance was $58.5 million and the Deflecto facility was $35.5 million. Shares outstanding were 96,460,378 as of September 30, 2025.
Acacia Research Corporation furnished a press release announcing its financial results for the quarter ended September 30, 2025. The release was provided under Item 2.02 and is attached as Exhibit 99.1. The company notes this information is being furnished and is not deemed “filed” under Section 18 of the Exchange Act, and it will not be incorporated by reference into Securities Act filings unless specifically referenced.
Exhibits include: 99.1 (Press Release dated November 5, 2025) and 104 (Cover Page Interactive Data File).
Gavin T. Molinelli, a director of Acacia Research Corp (ACTG), received 9,231 shares of the company's common stock on 09/30/2025 as payment in lieu of cash for director fees for Q3 2025. The shares were issued at a price of $3.25 per share. After the grant, Mr. Molinelli beneficially owned 160,218 shares of Acacia Research Corp.
The Form 4 was signed by Mr. Molinelli on 10/01/2025 and reports a routine, non-derivative acquisition of equity tied to director compensation. The filing shows direct ownership and does not report any derivative transactions.